Creative Medical Technology Holdings, Inc. (CELZ)

NASDAQ: CELZ · Real-Time Price · USD

3.310

+0.020 (0.61%)

At close: Sep 5, 2025, 4:00 PM

3.280

-0.030 (-0.91%)

After-hours: Sep 5, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Stem Cell Treatments	11.00K	Log In	Log In	Log In	Log In	Upgrade
Stem Cell Treatments Growth	22.22%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	11.00K	Log In	Log In	Log In	Log In	Upgrade
United States Growth	22.22%	Log In	Log In	Log In	Log In	Upgrade